Growth hormone and its disorders

被引:95
作者
Ayuk, J [1 ]
Sheppard, MC [1 ]
机构
[1] Univ Birmingham, Div Med Sci, Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England
关键词
D O I
10.1136/pgmj.2005.036087
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Growth hormone (GH) is synthesised and secreted by the somatotroph cells of the anterior lobe of the pituitary gland. Its actions involve multiple organs and systems, affecting postnatal longitudinal growth as well as protein, lipid, and carbohydrate metabolism. GH hypersecretion results in gigantism or acromegaly, a condition associated with significant morbidity and mortality, while GH deficiency results in growth retardation in children and the GH deficiency syndrome in adults. This article, aimed at non-paediatric physicians, examines the clinical features, diagnosis, and current concepts in the management of these conditions.
引用
收藏
页码:24 / 30
页数:7
相关论文
共 95 条
[1]
Cabergoline in the treatment of acromegaly: A study in 64 patients [J].
Abs, R ;
Verhelst, J ;
Maiter, D ;
Van Acker, K ;
Nobels, F ;
Coolens, JL ;
Mahler, C ;
Beckers, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (02) :374-378
[2]
Update on the diagnosis of GH deficiency in adults [J].
Abs, R .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 148 :S3-S8
[3]
EPIDEMIOLOGY OF ACROMEGALY IN THE NEWCASTLE REGION [J].
ALEXANDER, L ;
APPLETON, D ;
HALL, R ;
ROSS, WM ;
WILKINSON, R .
CLINICAL ENDOCRINOLOGY, 1980, 12 (01) :71-79
[4]
The effect of a new slow-release, long-acting somatostatin analogue, lanreotide, in acromegaly [J].
AlMaskari, M ;
Gebbie, J ;
KendallTaylor, P .
CLINICAL ENDOCRINOLOGY, 1996, 45 (04) :415-421
[5]
Mechanism of signaling by growth hormone receptor [J].
Argetsinger, LS ;
CarterSu, C .
PHYSIOLOGICAL REVIEWS, 1996, 76 (04) :1089-1107
[6]
Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379
[7]
Lanreotide 60 mg, a new long-acting formulation: Effectiveness in the chronic treatment of acromegaly [J].
Attanasio, R ;
Baldelli, R ;
Pivonello, R ;
Grottoli, S ;
Bocca, L ;
Gasco, V ;
Giusti, M ;
Tamburrano, G ;
Colao, A ;
Cozzi, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (11) :5258-5265
[8]
Gamma-knife radiosurgery in acromegaly: A 4-year follow-up study [J].
Attanasio, R ;
Epaminonda, P ;
Motti, E ;
Giugni, E ;
Ventrella, L ;
Cozzi, R ;
Farabola, M ;
Loli, P ;
Beck-Peccoz, P ;
Arosio, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (07) :3105-3112
[9]
The role of growth hormone-receptor antagonism in relation to acromegaly [J].
Ayuk, J ;
Sheppard, MC .
EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (11) :2279-2285
[10]
Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly [J].
Ayuk, J ;
Clayton, RN ;
Holder, G ;
Sheppard, MC ;
Stewart, PM ;
Bates, AS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (04) :1613-1617